Nine Frontier Medical: has repurchased 10,566,300 shares, using a total amount of funds of 425 million yuan.

On December 1st, Jiuan Medical announced that the company held the 27th meeting of the sixth board of directors on October 13, 2025, and reviewed and approved the "Proposal on the Company's Share Repurchase Plan." The source of funds for this repurchase comes from the company's own funds and specialized repurchase loan funds, with a total amount of repurchase funds not less than 300 million yuan and not more than 600 million yuan. The repurchase price of the shares shall not exceed 53.5 yuan per share. As of November 30, 2025, the company has repurchased a total of 10.5663 million shares, accounting for 2.27% of the total share capital of the company. The repurchase price range is from 39.598 yuan per share to 41.6 yuan per share, with a total fund usage of 425 million yuan.